212 related articles for article (PubMed ID: 28262615)
21. Cryptotanshinone Reverses Cisplatin Resistance of Human Lung Carcinoma A549 Cells through Down-Regulating Nrf2 Pathway.
Xia C; Bai X; Hou X; Gou X; Wang Y; Zeng H; Huang M; Jin J
Cell Physiol Biochem; 2015; 37(2):816-24. PubMed ID: 26356271
[TBL] [Abstract][Full Text] [Related]
22. Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins.
Kim SJ; Park C; Lee JN; Lim H; Hong GY; Moon SK; Lim DJ; Choe SK; Park R
Toxicol Appl Pharmacol; 2015 Oct; 288(2):192-202. PubMed ID: 26193055
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis induced by bruceine D in human non‑small‑cell lung cancer cells involves mitochondrial ROS‑mediated death signaling.
Xie JH; Lai ZQ; Zheng XH; Xian YF; Li Q; Ip SP; Xie YL; Chen JN; Su ZR; Lin ZX; Yang XB
Int J Mol Med; 2019 Dec; 44(6):2015-2026. PubMed ID: 31638181
[TBL] [Abstract][Full Text] [Related]
24. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
25. Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin.
Shiu LY; Chang LC; Liang CH; Huang YS; Sheu HM; Kuo KW
Food Chem Toxicol; 2007 Nov; 45(11):2155-64. PubMed ID: 17619073
[TBL] [Abstract][Full Text] [Related]
26. Neferine and isoliensinine enhance 'intracellular uptake of cisplatin' and induce 'ROS-mediated apoptosis' in colorectal cancer cells - A comparative study.
Manogaran P; Beeraka NM; Huang CY; Vijaya Padma V
Food Chem Toxicol; 2019 Oct; 132():110652. PubMed ID: 31255669
[TBL] [Abstract][Full Text] [Related]
27. A novel synthetic analog of Militarin, MA-1 induces mitochondrial dependent apoptosis by ROS generation in human lung cancer cells.
Yoon DH; Lim MH; Lee YR; Sung GH; Lee TH; Jeon BH; Cho JY; Song WO; Park H; Choi S; Kim TW
Toxicol Appl Pharmacol; 2013 Dec; 273(3):659-71. PubMed ID: 24161344
[TBL] [Abstract][Full Text] [Related]
28. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial DNA mutations are involved in the acquisition of cisplatin resistance in human lung cancer A549 cells.
Horibe S; Ishikawa K; Nakada K; Wake M; Takeda N; Tanaka T; Kawauchi S; Sasaki N; Rikitake Y
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34935060
[TBL] [Abstract][Full Text] [Related]
30. Bcl-2 overexpression reduces cisplatin cytotoxicity by decreasing ER-mitochondrial Ca2+ signaling in SKOV3 cells.
Xu L; Xie Q; Qi L; Wang C; Xu N; Liu W; Yu Y; Li S; Xu Y
Oncol Rep; 2018 Mar; 39(3):985-992. PubMed ID: 29286126
[TBL] [Abstract][Full Text] [Related]
31. Sirt5 Attenuates Cisplatin-Induced Acute Kidney Injury through Regulation of Nrf2/HO-1 and Bcl-2.
Li W; Yang Y; Li Y; Zhao Y; Jiang H
Biomed Res Int; 2019; 2019():4745132. PubMed ID: 31815138
[TBL] [Abstract][Full Text] [Related]
32. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
Liu M; Qi Z; Liu B; Ren Y; Li H; Yang G; Zhang Q
Oncotarget; 2015 Sep; 6(28):25281-94. PubMed ID: 26325371
[TBL] [Abstract][Full Text] [Related]
33. p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax.
Kim CW; Lu JN; Go SI; Jung JH; Yi SM; Jeong JH; Hah YS; Han MS; Park JW; Lee WS; Min YJ
Int J Oncol; 2013 Nov; 43(5):1495-502. PubMed ID: 23970333
[TBL] [Abstract][Full Text] [Related]
34. Dendrobine targeting JNK stress signaling to sensitize chemotoxicity of cisplatin against non-small cell lung cancer cells in vitro and in vivo.
Song TH; Chen XX; Lee CK; Sze SC; Feng YB; Yang ZJ; Chen HY; Li ST; Zhang LY; Wei G; Shi J; Xu K; Ng TB; Zhu LL; Zhang KY
Phytomedicine; 2019 Feb; 53():18-27. PubMed ID: 30668397
[TBL] [Abstract][Full Text] [Related]
35. Intricatinol synergistically enhances the anticancerous activity of cisplatin in human A549 cells via p38 MAPK/p53 signalling.
Singh VK; Arora D; Satija NK; Khare P; Roy SK; Sharma PK
Apoptosis; 2017 Oct; 22(10):1273-1286. PubMed ID: 28756530
[TBL] [Abstract][Full Text] [Related]
36. Involvement of the mitochondrial pathway in bruceine D-induced apoptosis in Capan-2 human pancreatic adenocarcinoma cells.
Liu L; Lin ZX; Leung PS; Chen LH; Zhao M; Liang J
Int J Mol Med; 2012 Jul; 30(1):93-9. PubMed ID: 22552257
[TBL] [Abstract][Full Text] [Related]
37. BL-038, a Benzofuran Derivative, Induces Cell Apoptosis in Human Chondrosarcoma Cells through Reactive Oxygen Species/Mitochondrial Dysfunction and the Caspases Dependent Pathway.
Liu JF; Chen CY; Chen HT; Chang CS; Tang CH
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618007
[TBL] [Abstract][Full Text] [Related]
38. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
[TBL] [Abstract][Full Text] [Related]
39. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
Ni F; Yan CY; Zhou S; Hui PY; Du YH; Zheng L; Yu J; Hu XJ; Zhang ZG
Cancer Chemother Pharmacol; 2018 Oct; 82(4):593-605. PubMed ID: 30032449
[TBL] [Abstract][Full Text] [Related]
40. Betulin induces mitochondrial cytochrome c release associated apoptosis in human cancer cells.
Li Y; He K; Huang Y; Zheng D; Gao C; Cui L; Jin YH
Mol Carcinog; 2010 Jul; 49(7):630-40. PubMed ID: 20564340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
